In this review we explain: 1) the molecular mechanism by which de nervous system establishes communication between all their cells (neurons and glia), 2) the way by which this system organizes its confi guration (plasticity); in order to send signals, which form part of our behaviour, memory, thoughts, movements and all the functions that allow us to communicated with our environment and 3) the altered neurotransmission involved in brain diseases or disabilities.
Introduction
The neurotransmission may be defi ned as the set of biochemical and physiochemical signals, which establishes neuronal communication. Each neuron is connected with numerous other neurons in a very specifi c shape forming a neuronal network, which may change during the life according to environmental signals. This process is called neuronal plasticity. These changes may be produced in adult and young brains, although during the developing brain is higher as compared to the adult brain [1] [2] [3] .
The variety of physicochemical signals that neurons may process could lead to a great quantity of transduction mechanisms. However, the evolution has only used a few mechanisms to process all signals. Synaptic plasticity is crucial for regulating synaptic transmission or neuronal connectivity in order to share essential information among neurons and glia cells and maintaining homeostasis in the body.
Neuroplasticity is the capacity of the central nervous system to undergo structural changes as adaptive response against different stimulus. Structural plasticity is the brain ability to change its structure as consequence of learning and learning or structural remodelling under CNS damage in pathological conditions by neuroprotective drugs [4] [5] [6] [7] . Several mechanisms contribute to brain plasticity including an over-production of neurons and synapses during the early development and apoptosis [8] .
This review focuses on synaptic phenomena involved in homeostatic plasticity. We also explain the relevance of neuronal plasticity and the relationship between neurotransmission and physiological dysfunctions. In addition, we discuss a putative modulation of the signalling mechanisms involved in homeostatic functions and neuronal remodelling as well as therapeutic approach against neurological and neurodegenerative disorders.
Synaptic plasticity and function
The neurons are connected among them forming structures named synapses that make them suitable the neuronal the disease brain. J Neurol Neurol Sci Disord 5(1): 038-046. DOI: http://dx.doi.org/10.17352/jnnsd.000032 intercommunication and govern all vital and cognitive functions.
The synapse is a structure formed by the axon terminal of a neuron named presynaptic and another postsynaptic neuron, which are separated by the synaptic clefts. In the axon of the presynaptic neuron neurotransmitters are inside of synaptic vesicles. The postsynaptic neuron is the cell that recruits the neurotransmitter receptors and received their signals. Astrocytes are surrounding the synapses attending several functions, such as the elimination of the neurotransmitter to stop the neurotransmission [7, [9] [10] [11] [12] [13] or maintaining the position of all cells that make up the cells of the CNS among other (Figure 1 ).
It is estimated that the adult brain has, at least, 10 14 synaptic connections.
The synapse is the structure where the neurons establish their communication. Therefore, it is highly regulated not only respect to the neurotransmitter release but also with regard its conformation (synaptic plasticity).
The synapse plasticity includes different facets at different levels: 1) presynaptic levels, 2) neurotransmitter removal and 3) postsynaptic levels.
Presynaptic level
At the presynaptic level, there are sequences of events which conclude with the neurotransmitter release. In the end of nervous terminal, the synaptic vesicle (SV) are docking by proteins from cytoskeleton, mainly actin ( Figure 3 ). A single neuron can participate in over 100.000 synapses in the mouse and over one million synapses in the human brain [9] . Astrocytes regulate several aspects in the synapses as formation, maturation and functions taking part in the uptake of some neurotransmitter [14] . In addition, they may control the ionic balance at the synapses including Ca 2+ and K + ions [15, 16] . Astrocytes also secrete factors inductors of synaptogenesis and of specifi c excitatory and inhibitory circuit formation [17] [18] [19] [20] .
Several synapses types exist, depending on the connection among neurons. These may be a) axo-somatic, when the axon The Ca
2+
, which has gone inside the neuron through voltage dependent Ca 2+ channels, is bound to some cytoskeleton proteins (actin). These actin proteins are polymerized forming fi laments which cross each other docking several cellular organelles, between them the SV. In presence of Ca 2+ , the actin fi laments are depolymerized and as consequence the SV remains free and may approach to the presynaptic membrane. In this case, the Ca 2+ acts as an intracellular messenger. When this protein bounds GTP forms a complex, the Rab-GTP, which it is able to bind to the synaptic vesicle. The formation of GTP is mediated by a guanine nucleotide exchange factor (GEF) located at the presynaptic membrane.
2) The complex Rab-GTP bounds to the proteins vesicular SNARE (v-SNARE,) located in the SV, forming a complex Rab-GTP-SV. This makes that the SV moves toward the presynaptic membrane and recognizes a receptor denominated effecter Rab.
3) Rab-GTP-SV is bounded to this effector (forming Rab-GTP-effector Rab-SV) and also to a group of proteins located in SV and in the cellular membrane (the v-SNARE, located in SV, and the t-SNARE, located in the cellular membrane). This makes that both membranes (the cellular and the vesicular) stay very close.
4)
When the SV is near to the presynaptic membrane, both proteins t-SNARE and v-SNARE roll up themselves forming a stable complex denominated trans-SNARE. This causes a greater approximation between SV and presynaptic membrane. After that, the GTP, linked to Rab, is hydrolyzed producing Rab-GDP (soluble), and P. This makes that SV to separate from the Rab-GTP-effector Rab-SV complex to free the SV, which is anchored to the presynaptic membrane.
5)
Once this process take place, the SNARE separates from this complex, and a signalling protein, denominated N-ethylmaleimide-sensitive factor (NSF), is activated by ATP with the mediation of an ATP-ase enzyme. NSF is linked to an adapter protein and to SV. In this process, ATP is hydrolyzed and its energy is used to unroll the SNARE (v-SNARE and t-SNARE). Both SNARES and other not well identifi ed proteins (although it could be possible that some of them were synaptophysin and synaptobrevin) give place to a pore formation by which SV may release the neurotransmitter [22] [23] [24] [25] [26] (Figure 4 ).
Elimination of neurotransmitter from the synaptic clefts
The presence of the neurotransmitter in the synaptic space should be very short and the neurotransmitter needs to disappear from this area. This process may be performed by several mechanisms: (a) its removal by enzymes located at the pre and postsynaptic neuron membrane (i.e: acetylcholine) and (b) by neurotransmitter transporters located in neurons and astrocytes situated in the synaptic space ( Figure 1 ). This way is used for amino acid neurotransmitters.
Postsynaptic levels
The neurotransmitter is bound to specifi c postsynaptic receptors, which respond with specifi c cellular signals, like the entry of Na + and Ca 2+ ions into the postsynaptic neuron. In this area is where the long-term potentiation (LTP) and the longterm depression (LTD) takes place. The physical and biological mechanism of LTP is not well understood, but several models have been developed. LTP may mean memory consolidation and LTD long-term memory depression. Several forms of LTP exist depending on the brain area and the age of the organism. For example, the molecular mechanism of LTP of the adult hippocampus differs from the young hippocampus [27] . The signals pathways, used by each cell, contributes to the LTP specifi city. Like this, some types of hippocampal LTP depend on the NMDA receptor and other depends on the metabotropic glutamate receptor (mGluR) or upon other molecule.
The induction of the LTP and LTD is dependent on the postsynaptic increase in intracellular Ca 2+ . Ca 2+ activates several enzymes as phosphatase, calcineurin, calcium/calmodulin dependent protein kinase II (CaMKII), and protein kinase C (PKC), some of them are necessaries to fi re LTP. The activation of these enzymes plays a regulatory role during synaptic plasticity as well as during the induction of the LTP and learning.
Some authors suggest that the LTP induction needs CaMKII activation in the hippocampus, Calmodulin mediates the activation of this enzyme, which previously has been activated by the Ca 2+ increase. However, other authors suggest that is not necessary CaCMII activation to induce LTP. Therefore, the PKC activation seems to be necessary for both LTP and memory maintenance [28, 29] . LTP is related with the memory mechanism [30, 31] . At the end of the XIX century, the scientifi c believed that the memory was associated to higher number of neurons number but soon they realised that this was not the explanation. In 
Glutamate as inductor of LTP in the postsynaptic area
Glutamate is the major excitatory neurotransmitter in the brain. It activates several receptors (ionotropic and metabotropic) at the postsynaptic neurons. The ionotropic receptors NMDA and AMPA are important in the hippocampal synaptic plasticity and LTP induction [35, 36] . When NMDA receptor is activated, a great Ca 2+ fl ux takes place inside the postsynaptic neuron. This Ca 2+ increase is necessary for LTP induction. However, the NMDA need not only the postsynaptic depolarization for activation but also the presynaptic transmitter release to induce LTP. On the contrary, AMPA receptors are suffi cient for the expression of the LTP due to the fact that after its activation, news AMPA receptors could be incorporated to the postsynaptic membrane ( Figure 5 ). The mechanism is as follows:
1. The glutamate release by the presynaptic neuron is bound to NMDA and AMPA receptors in the postsynaptic membrane.
2. AMPA receptor is a Na + channel; therefore, the Na + entry induces both membrane depolarization and opening of voltage dependent Ca 2+ channels.
3.
NMDAR is a Ca 2+ channel, then, Ca 2+ enters inside the postsynaptic neuron and activates the calmodulin (CaM), this activates calcium/calmodulin dependent protein kinase II (CaMKII) which it is the responsibility that AMPA receptor moves through the membrane postsynaptic leading to more AMPA receptors in this site and as consequence a long time of excitation.
Involvement of glial cells in neuroplasticity: Astrocytes
Astrocytes represent the most abundant population of glia in the mammalian brain and are crucial for the functions of the nervous system as trophic support to neurons [37] and it is also involved in neurotransmission [38] . They establish close contacts with neurons and blood vessel and envelope thousands of synapses [39] . In addition, astrocytes participated actively in the maintenance of the health and activity neuronal [40, 41] , including regulation of the synaptic formation, transmission, neuromodulation and plasticity. The mechanism by which astrocytes perform these effect is through the release of different molecules like thrombospondin [42] , and cholesterol [43] among others.
Astrocytes express several receptors among them the purinergic, adrenergic, glutamatergic and GABAergic [44] [45] [46] [47] .
Astrocytes remove excess of glutamate after glutamatergic transmission, transforming it in glutamine and returning it to the neurons as glutamate [45] . In addition, astrocytes control the ionic balance at the synapse, including Ca 2+ and K + ions that are crucial for synaptic neurotransmission [44, 48] .
It has been thought for a long time that astrocytes were not excitable; nevertheless, astrocyte excitability is manifested by the elevation of cytosolic Ca 2+ mainly as result of endoplasmic reticulum mobilization of Ca 2+ [49] . These results suggest that astrocytes may be capable to mediate in neurotransmission and affect neuronal activity. Astrocytes can release neuroactive substances denominated gliotransmitters that can bind to presynaptic and/or postsynaptic receptors and also can regulate neuronal excitability and synaptic transmission [50] [51] [52] .These results confi rmed than astrocytes are integral elements of the synapse. The gliotransmitter release may be Ca 2+ dependent, vesicular release as in neurons, and Ca 2+ independent. Astrocytes express synaptotagmin IV and SNARE type proteins which regulated the glutamate and other neurotransmitters release by a vesicular way [53] . No vesicular gliotransitter release is performed through reversion of transporters uptake [54] . It is now accepted that astrocytes and neurons work together, so, the neuronal activity induces gliotransmitters release. This mechanism is performed via G couple receptors. Astrocytes have receptors type couple to G-proteins, therefore, after neurotransmitter release by the presynaptic neuron, this is bounded to its specifi c receptor (receptor couple to G protein) in the astrocyte, leading to an increase in IP3. IP3 is bounded to IP3 receptor in the endoplasmic reticulum which promote Ca 2+ exit from this cellular compartment and Ca 2+ lead to rises in the cytosol and as consequence the release mediated by gliotransmitters.
Although Ca 2+ dependent signaling pathway in astrocytes are functional in healthy brain tissues, elevation in Ca 2+l levels may be associated to neuronal dysfunctions such as epilepsy [55] , Alzheimer diseases [56] and stroke [57] . This may signify that the regulation of the gliotransmision is important. Some authors think that this regulation may carry out as consequence of excitotoxic events that are commun to these diseases. These toxics molecules can be release from damage cells [58] and activate microglia and astrocytes, inducing the release of proinfl ammatory cytokines and chemokines [59] , that provoke astrocytes damage as consequence of alterations in neuronal functions and death.
Signalling from synapses to nucleus
The feature that gene expression could be mediated via neuronal activity was known through the observation that agonist of the nicotinic acetylcholine receptor and other neurotransmitters that induce membrane depolarization and Ca 2+ entry through voltage dependent Ca 2+ channels also might express c-fos in neurons [60] . Later, different research found that other genes were also lead by this mechanism [61, 62] . For instance, L-type voltage dependent Ca 2+ channels induces expression of protein kinase A type (AKAP79/150), tyrosine kinase Src and phosphatase calcineurin [69] .
Some of these induce phosphorylation of the L-type voltage dependent Ca 2+ channels inhibiting the Ca 2+ entering through these transports. Calcineurin activation is necessary for the translocation.
NMDA and AMPA receptors have several types of subunits and according that these receptors may be Ca 2+ or Na + channels. This mean that the genes that these receptor express will be different. Calcium infl ux through NMDA receptor activates receptors such as Rac, GEFs, beta-PIX and Kalirin-7 [70, 71] . All this suggests that the signalling mechanism of neurotransmission induces gene expression in the nucleus and when this mechanism falls it may causes several neurological disorders. dependent channels or Ca 2+ entry through NMDA receptor in excitatory neurons [72] . Other signals may be transport from the synapses to the cellular nucleus through the slow retrograde axonal transport [73] Disease caused by dysfunction of the neurotransmission and therapeutic strategies In this review, examples of diseases that occur due to neurotransmission dysfunctions will be presented.
Myasthenia syndromes:
The most of diseases from congenital myasthenia syndromes (CNS) are characterized, among other symptoms, by cognitive dysfunctions and astrocytes abnormalities [74] , suggesting a crucial role of these cells in normal cognitive and function. CNS pathologies are a group of neurological diseases characterized by weakness and fatigability [75] . Many of these diseases are due to genes encoding pro- teins of the presynaptic region some of them associated with the SNARE complex [76] Brain ischemia: During brain ischemia there are a lack of O 2 and glucose and as consequence low ATP because neurons containing few storage glycogen, then the neurons dye; however, astrocytes may maintained during more time the production of energy (ATP) under hypoxia conditions because they have higher glycogen as reserve [77] . Therefore, during ischemia astrocytes may increase the neurons survival at expense of the lactate submitted by these cells as result of anaerobic glucose degradation [78] .
Alzheimer disease: The Alzheimer disease is characterized by the decrease of the cholinergic system then, the use of inhibitors of acetylcholinesterase enzyme was considered as a good treatment to improve cholinergic neuronal function.
Astrocytes express nicotinic receptors from the 7 type ( nAChR) [79] , therefore, the use of inhibitor of AChE (AChEIs) make that astrocytes kept during more time the acetylcholine in the synaptic cleft, favoring the cholinergic transmission.
In addition, AChEIs also reduce ROS production and apoptosis [80] . Makatani et al, 2017 [81] consider that protective mechanisms due also to nicotinic actions through PI3K-Akt pathways may also be effi cient in Alzheimer, although this disease is incurable.
Schizophrenia: Schizophrenia (SZ) is a complex and heterogeneous psychiatric disorder characterized by a group of symptoms including delusions, hallucinations, impaired cognitive functioning, disorganized speech and behaviour [82] .
The Schizophrenia etiology is unknown, the illness implies genetic, environmental and epigenetic factors. Several studies have related alterations in the neurotransmission mediated by biogenic amines, and at dysfunctions in glutamic, dopamine and GABAergic neurotransmission [83, 84] .
Epilepsy: Epilepsy is a disease known in the times of
Hippocrates being call and 'shaking palsy'. During many times was considered as the result of a demonic possession. In 1929 the invention of electroencephalography transformed the epilepsy into a well-defi ned syndrome and due to this method it was demonstrated that this disease was due to abnormal brain waves which produced hypersynchronous discharge of large populations of neurons in the brain. Epilepsy may be produced by imbalances in neurotransmitters and mutations in their receptors, ion channels, transporters and altered network connectivity (plasticity) [85, 86] . It is classifi ed into two categories genetic and idiopathic. Genetic may be caused for changes in a single protein while idiopathic is due to a polygenic disorder.
Several biological changes have been described during epileptogenesis including gliosis [87] , uncontrolled infl ammation [88] , disruption of the blood-brain barrier [89] , neurodegeneration [90] , changes in neuronal circuits [91] , aberrant neurogenesis, promotes release of glutamate with the subsequent neuronal cells death [92] . All these alteration are the responsible of the horrifying syndrome in this disease.
Down syndrome: Down syndrome is a genetic disease that occurs due to an aneuploidy of human chromosome 21 . This leads to a set of cognitive anomalies and learning defi cits. The disease course with defi ciencies in GABA-ergic neurotransmission, noradrenergic neuronal loss, anomalous glutamatergic and NMDA receptor signalling, mitochondrial dysfunction and infl ammation [93] .
Other disease related with neurotransmission are Parkinson, with failure and death of dopaminergic neurons.
Autism characterized by a spectrum of disorder characterized by impaired social communication, social interaction and repetitive behaviours [94] .
Conclusion
Since brain disorders affects neurotransmission it is crucial to understand signalling pathways by which neurodegeneration alters neurotransmitter levels. Thus, the analysis of neurotransmission could help to understand possible role of neurotransmitters in neuroprotection by pharmacological approaches. In addition, the neurotransmission is important for understanding learning and memory processes and also neurorepair mechanisms in the injured brain. Neurotransmitters like glutamate, GABA, etc could be associated markers of neuroprotective drugs in neurodegenerative diseases.
